Macroview Investment Management LLC Blueprint Medicines Corp Transaction History

Macroview Investment Management LLC

  • $96.8 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024
BUY
$85.18 - $108.78 $5,962 - $7,614
70 New
70 $7,000
Q1 2022

May 02, 2022
SELL
$54.1 - $110.08 $9,575 - $19,484
-177 Closed
0 $0
Q4 2021

Jan 25, 2022
BUY
$94.25 - $115.99 $16,682 - $20,530
177 New
177 $19,000
Q4 2020

Jan 29, 2021
SELL
$92.08 - $124.48 $2,762 - $3,734
-30 Closed
0 $0
Q3 2020

Oct 23, 2020
SELL
$66.45 - $92.7 $664 - $927
-10 Reduced 25.0%
30 $3,000
Q2 2020

Aug 11, 2020
BUY
$57.09 - $79.27 $2,283 - $3,170
40 New
40 $3,000

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.65B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email